HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of 99mTc phosphate and diphosphonate complexes in experimental renal infarcts.

Abstract
The 3-hour biodistribution of 99mTc complexes of five diphosphonates (HMDP, NMMDP, DMAD, DPD, and APD), imidodiphosphonate (IDP), and pyrophosphate (PYP) was compared in rats with segmental renal infarction induced by a 1-hour occlusion of a renal artery branch. 95mTc labeled MDP was a reference substance in all animals. Three agents (APD, HMDP and IDP) had a higher infarct/normal kidney concentration ratio than MDP, the latter two by virtue of a lower content in normal kidney. HMDP, DPD, and IDP had very high liver concentrations. DPD showed relatively high concentrations in soft tissues and blood. The blood and kidney levels of PYP were higher than those of MDP but the infarct/normal kidney ratios were similar. None of the agents had a higher uptake in bone than MDP: four had a significantly lower uptake. The increased concentration of 99mTc MDP in the infarcts was readily seen in camera images one day after renal artery occlusion, but not at three or seven days. Increased diphosphonate uptake was accompanied by an influx of calcium in both cortex and medulla. The accumulation of diphosphonate in areas of infarction was not modified by infusions of verapamil or Captopril.
AuthorsJ G McAfee, D J Krauss, G Subramanian, F D Thomas, M Roskopf, C Ritter, B Lyons, J E Schoonmaker, R D Finn
JournalInvestigative radiology (Invest Radiol) 1983 Sep-Oct Vol. 18 Issue 5 Pg. 479-84 ISSN: 0020-9996 [Print] United States
PMID6315629 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Diphosphates
  • Diphosphonates
  • Technetium
Topics
  • Animals
  • Diphosphates (metabolism)
  • Diphosphonates (metabolism)
  • Infarction (diagnostic imaging)
  • Kidney (blood supply)
  • Male
  • Radionuclide Imaging
  • Rats
  • Rats, Inbred Strains
  • Technetium
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: